ReviewDrug safety2004
A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Milind P Sovani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled ittrialcites it